Monday, December 23, 2024
HomeTagsDK210

DK210

Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

Deka Biosciences, a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced that the U.S. Food and Drug...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics